HR021618 + HR021618 + Placebo
Phase 2UNKNOWN 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Postsurgical Pain Management
Conditions
Postsurgical Pain Management
Trial Timeline
Dec 17, 2020 → Aug 8, 2021
NCT ID
NCT04699175About HR021618 + HR021618 + Placebo
HR021618 + HR021618 + Placebo is a phase 2 stage product being developed by Jiangsu Hengrui Medicine for Postsurgical Pain Management. The current trial status is unknown. This product is registered under clinical trial identifier NCT04699175. Target conditions include Postsurgical Pain Management.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04699175 | Phase 2 | UNKNOWN |
Competing Products
1 competing product in Postsurgical Pain Management
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| SHR0410 Injection + Placebo for SHR0410 Injection | Jiangsu Hengrui Medicine | Phase 2 | 52 |